Pfizer Stock News

Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less effective the vaccine is. According to the same data gleaned from the blood plasma taken from 12 patients who tested positive for omicron, the team found that a two-shot course of Pfizer''s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, though it can thwart severe disease, according to laboratory experiments in South Africa, according to Bloomberg. The data comes courtesy of a team of researchers at the Africa Health Research Institute in Durban. Though data has been pouring out about omicron, and sometimes individual studies reach opposing findings, the general consensus is that omicron will be able to more easily evade protection afforded from the first generation of vaccines - however, the scientists say that people will still be protected against severe disease and death.

Young children have been eligible to receive the Pfizer vaccine for about a month. In that time, Santa Cruz County has vaccinated 4,744 children in the 5-11 age group, according to the countys vaccine dashboard. Santa Cruz County schools vaccinated 4,054 of them, according to County Superintendent of Schools Faris Sabbah.

Independence Bank of Kentucky cut its stake in Pfizer Inc. (NYSE:PFE) by 3.4% in the third quarter, Holdings Channel reports. The firm owned 73,562 shares of the biopharmaceutical companys stock after selling 2,627 shares during the period. Pfizer comprises 1.4% of Independence Bank of Kentuckys holdings, making the stock its 18th largest position. Independence Bank []

Have Professional Athletes Become The Canary-In-The-COVID-Coalmine? Authored by Robert Bridge via The Strategic Culture Foundation, The sudden spate of on-field emergencies has raised questions among several seasoned veterans of the game Amid studies showing a link between some vaccines and heart problems, professional athletes appear to be collapsing on the field of dreams like never before. Are these incidences normal occurrences, coincidences or symptomatic of mandatory vaccine programs? As more countries make vaccinations mandatory requirements for participating in many aspects of life, including that of sporting events, stadiums around the world have become something of testing grounds for determining the efficacy of the rollout. Thus far the results do not look particularly promising. Last month, the world of female rugby was rocked by the news that Scottish sensation Siobhan Cattigan, 26, died suddenly in non-suspicious circumstances, as the Daily Mail reported. Yet anytime a young person not least of all a healthy star athlete dies unexpectedly there is some inherent element of suspicion involved.

Krilogy Financial LLC increased its stake in Pfizer Inc. (NYSE:PFE) by 4.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,164 shares of the biopharmaceutical companys stock after acquiring an additional 566 shares during the period. Krilogy Financial []

Balasa Dinverno & Foltz LLC grew its holdings in shares of Pfizer Inc. (NYSE:PFE) by 13.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 80,229 shares of the biopharmaceutical companys stock after acquiring an additional 9,446 shares during the quarter. []

Balasa Dinverno & Foltz LLC boosted its stake in shares of Pfizer Inc. (NYSE:PFE) by 13.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 80,229 shares of the biopharmaceutical companys stock after purchasing an additional 9,446 shares during []

Highland Capital Management LLC raised its position in Pfizer Inc. (NYSE:PFE) by 6.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 86,991 shares of the biopharmaceutical companys stock after purchasing an additional 5,155 shares during the quarter. Highland Capital Management LLCs holdings []

Saturday marks one year since the Food and Drug Administration authorized Pfizer''s COVID-19 vaccine.

Pfizer Inc. (NYSE:PFE) announced a quarterly dividend on Friday, December 10th, RTT News reports. Stockholders of record on Friday, January 28th will be given a dividend of 0.40 per share by the biopharmaceutical company on Friday, March 4th. This represents a $1.60 annualized dividend and a dividend yield of 3.03%. This is an increase from []

Theres a public health challenge that has been lurking and largely ignored in the US, and that could become a major issue if the omicron variant of Covid-19 becomes dominant: the one-dose problem. There appear to be millions of Americans walking around who have received a single dose of a Covid-19 vaccine, who may think [] The post One dose of Pfizer or Modernas Covid vaccine wont stop omicron appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

An analysis from the UK Health Security Agency (UKHSA) has found that Pfizer/BioNTech and AstraZeneca vaccines provide much lower levels of protection against symptomatic infection with Omicron when compared to Delta. However, preliminary data has suggested that effectiveness seemed to increase considerably in the early period of a booster dose, offering 70-75% protection against symptomatic []

Related Stocks: LSEG , STZ , WSM , MDT , LUV , PFE , PCAR , PZZA , ONTF , MRVL , KSU , UNF , PYPL , KEY , KSS , COP ,